Peptidomimetic PKB/Akt inhibitors as anti-cancer drug leads

Yftah Tal-Gan; S. Klein; A. Levitzki; C. Gilon

Peptidomimetic PKB/Akt inhibitors as anti-cancer drug leads

Yftah Tal-Gan, S. Klein, A. Levitzki, C. Gilon

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Pages (from-to)	93-94
Number of pages	2
Journal	Journal of Peptide Science
Volume	16
State	Published - Sep 2010

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{7a359f07e0104a13984f7aa78f694eef,

title = "Peptidomimetic PKB/Akt inhibitors as anti-cancer drug leads",

author = "Yftah Tal-Gan and S. Klein and A. Levitzki and C. Gilon",

year = "2010",

month = sep,

language = "אנגלית",

volume = "16",

pages = "93--94",

journal = "Journal of Peptide Science",

issn = "1075-2617",

publisher = "John Wiley and Sons Ltd",

}

TY - JOUR

T1 - Peptidomimetic PKB/Akt inhibitors as anti-cancer drug leads

AU - Tal-Gan, Yftah

AU - Klein, S.

AU - Levitzki, A.

AU - Gilon, C.

PY - 2010/9

Y1 - 2010/9

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=starter5-25&SrcAuth=WosAPI&KeyUT=WOS:000281610800227&DestLinkType=FullRecord&DestApp=WOS_CPL

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.abstract???

SN - 1075-2617

VL - 16

SP - 93

EP - 94

JO - Journal of Peptide Science

JF - Journal of Peptide Science

ER -

Peptidomimetic PKB/Akt inhibitors as anti-cancer drug leads

UN SDGs

Other files and links

Cite this